 Shares of Chembio Diagnostics Inc. rocketed 102 on heavy volume in premarket trading Wednesday, infectious diseases diagnostic company announced a 28.3 million purchase order its SARS-CoV-2 antigen tests from Brazil-based Bio-Manguinhos. Trading volume spiked to 22.3 million shares, compared with the full-day average of about 525,100 shares. 